A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor patient prognosis and limited therapeutic options. A lack of prognostic biomarkers and therapeutic targets fuels the need for new approaches to tackle this severe disease. Extracellular matrix degradation, release,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yueyang, Gong, Weiwei, Preis, Sarah, Dorn, Julia, Kiechle, Marion, Reuning, Ute, Magdolen, Viktor, Dreyer, Tobias F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605449/
https://www.ncbi.nlm.nih.gov/pubmed/36294951
http://dx.doi.org/10.3390/life12101517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605449/
https://www.ncbi.nlm.nih.gov/pubmed/36294951
http://dx.doi.org/10.3390/life12101517

Ejemplares similares